Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder. Am J Psychiatry. 1994;151(Dec. Suppl.).
Baastrup PC, Ahlfors UG, Bjerkenstedt et al. A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis. Acta Psychiatr Scand. 1993;87:48–58.
Banov MD, Zarate CA Jr, Tohen M et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry. 1994;55:295–300.
Barbini B, Scherillo P, Benedetti F, Crespi G, Colombo C, Smeraldi E. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol. 1997;12:109–12.
Battegay R, Cotar B, Fleischhauer J et al. Results and side effects of treatment with clozapine (Leponex). Compr Psychiatry. 1977;18:423–8.
Calabrese JR, Meltzer HY, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol. 1991;6:396–7.
Calabrese JR, Kimmel SE, Woyshville MJ et al. Clozapine in mania. Proceedings of the 32nd Annual Meeting of the American College of Neuropsychopharmacology; December 1993; Oahu, Hawaii, p. 150.
Calabrese JR, Kimmel SE, Woyshville MJ et al. Clozapine for treatment-refractory mania. Am J Psychiatry. 1996;153:759–64.
Chacko RC, Hurley RA, Jankovic J. Clozapine use in diffuse Lewy Body disease. J Neuropsychiatry Clin Neurosci. 1993;5:206–8.
Chakos MH, Alvir JM, Woerner MG et al. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Arch Gen Psychiatry. 1996;53:313–19.
Chou JCY, Zito JM, Vitrai J, Craig TJ, Allingham BH, Czobor P. Neuroleptics in acute mania: a pharmacoepidemiological study. Pharmacoepidemiology. 1996;30: 1396–8.
Cole JO, Banov MD, Green A et al. Clozapine in the treatment of refractory acute mania. In: New Research Program and Abstracts of the 146th Annual Meeting of the American Psychiatric Association; 26 May 1993; San Francisco, Calif. Abstract NR455:174.
Cooper, JE, Kendell RE, Gurland BJ et al. Psychiatric Diagnosis in New York and London: a Comparative Study of Mental Hospital Admissions. Institute of Psychiatry, Maudsley Monographs 20. London: Oxford University Press; 1972.
Cookson JC, Silverstone T, Wells B. A double-blind controlled study of pimozide vs. chlorpromazine in mania. Neuropharmacology. 1979;18:1011–13.
Cookson JC, Silverstone T, Wells B. Double-blind comparative trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis. Acta Psychiatr Scand. 1981;64:381–97.
Dassa D, Kaladjian A, Azorin JM et al. Clozapine in the treatment of psychotic refractory depression. Br J Psychiatry. 1993;163:822–4.
Delay J, Deniker P, Harl J. Utilization therapeutique psychiatrique ďune phenothiazine ďaction cetrale elective (4560 RP). Ann Med Psychol. 1952;110:112–17.
Faltus F, Hynek K, Dolezalova V et al. Experience in the treatment of schizophrenia with clozapine (letter). Activ Nerv Super (Prague). 1973;15:95.
Frankenburg FR. Clozapine in bipolar disorder. J Clin Psychopharmacol. 1993;13:289–90.
Gaertner HJ, Fischer E, Hoss J. Side effects of clozapine. Psychopharmacology (Berl). 1989;99:S97–100.
Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord. 1980;2:279–88.
Glazer WM, Morgenstern H. Predictors of occurrence, severity, and course of tardive dyskinesia in an outpatient population (Review; 37 refs). J Clin Psychopharmacol. 1988;9(4 Suppl.):10–16S.
Goodnick PJ. Risperidone treatment of refractory acute mania (letter). J Clin Psychiatry. 1995;56:431–2.
Gouliaev G, Licht RW, Vestergaard P, Merinder L, Lund H, Bjerre L. Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. Acta Psychiatr Scand. 1996, 93:119–24.
Hillert A, Maier W, Wetzel H et al. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome: a functional approach. Pharmacopsychiatry. 1992;25:213–17.
Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:423–9.
Janicak PG, Bresnahan DB, Sharma R, Davis JM, Comaty JE, Malinick C. A comparison of thiothixene with chlorpromazine in the treatment of mania. J Clin Psychopharmacol. 1988;8:33–7.
Jeste DV, Caligiuri MP, Paulsen JS et al. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry. 1995;52:756–65.
Juul Povlsen J, Noring U, Fog R et al. Tolerability and therapeutic effect of clozapine. Acta Psychiatr Scand. 1985;71:176–85.
Kane JM. The role of neuroleptics in manic-depressive illness. J Clin Psychiatry. 1988;49(11. Suppl.):12–13.
Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors. Arch Gen Psychiatry. 1982;39:473–81.
Keck PE Jr, Wilson DR, Strakowski SM et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry. 1995;56:466–70.
Kimmel SE, Calabrese JR, Meltzer HY. Clozapine in treatment refractory mania. In: 1993 CME Syllabus and Proceedings Summary of the Annual Meeting of the American Psychiatric Association; 24 May 1993; San Francisco, Calif. Abstract 21:80.
Klein DF. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry. 1967;16:118–26.
Kukopulos A, Reginaldi D, Laddomada P et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatrie-Neuropsychopharakol. 1980;13:156–67.
Leppig M, Bosch B, Naber D et al. Clozapine in the treatment of 12 out-patients. Psychopharmacology (Berl). 1989;99:S77–9.
Lindstrom LH. A retrospective study on the long-term efficacy of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year period. Psychopharmacology (Berl). 1989;99:S84–6.
McElroy SL, Dessain EC, Pope HG Jr et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry. 1991;52:411–14.
McElroy SL, Keck PE Jr, Stanton SP et al. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry. 1996;57:142–6.
McElroy SL, Frye MA, Denikoff KD et al. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord. 1998;49:19–22.
Morgenstern H, Glazer WM. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry. 1993;50:723–33.
Naber D, Leppig M, Grohmann R et al. Efficacy and adverse effects with clozapine in the treatment of schizophrenia and tardive dyskinesia: a retrospective study of 387 patients. Psychopharmacology (Berl). 1989;99:S73–6.
Naber D, Hippius H. The European experience with use of clozapine. Hosp Community Psychiatry. 1990;41:886–90.
Naber D, Hozbach R, Perro C et al. Clinical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry. 1992;160:54–9.
Nasarallah HA, Churchill CM, Hamdan-Allan GA. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry. 1988; 145:1455–6.
Owen RR, Beake B, Marby D et al. Response to clozapine in chronic psychotic patients. Psychopharmacol Bull. 1989;25:253–6.
Parsa MA, Ramirez LF, Loula CE et al. Effect of clozapine on psychotic depression and Parkinsonism. J Clin Psychopharmacol. 1991;11:330–1.
Pickar D, Owen RR, Litman RE et al. Clinical and biologic response to clozapine in patients with schizophrenia. Arch Gen Psychiatry. 1992a;49:345–53.
Pickar D, Owen RR, Litman RE et al. Clinical and biologic response to clozapine in patients with schizophrenia. Arch Gen Psychiatry. 1992b;49:345–53.
Platman SR. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry. 1970;127:127–9.
Prien RF, Caffey EM Jr, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiatry. 1972;26:146–53.
Privitera MR, Lamberti JS, Maharaj K. Clozapine in a bipolar depressed patient (letter). Am J Psychiatry. 1993;150:986.
Rifkin A, Doddi S, Karajgi B, Borenstein M, Munne R. Dosage of haloperidol for mania. Br J Psychiatry. 1994;165:113–16.
Rodova A, Suestka J, Nanhunek K et al. A blind comparison of clozapine and perphenazine in schizophrenics. Activ Nerv Super (Prague). 1973;94–5.
Sajatovic M, Verbanac P, Ramirez LF et al. Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington’s chorea (letter). Neurology. 1991;41:156.
Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacol. 1998;21:176–80.
Shopsin B, Gershon S, Thompson H, Collins P. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry. 1975;32:34–42.
Singh AN, Catalan J. Risperidone in HIV-related manic psychosis. Lancet. 1994;344:1029–30.
Small JG, Milstein V, Marhenke JD et al. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. J Clin Psychiatry. 1987;48:263–7.
Suppes T, McElroy SL, Gilbert J et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry. 1992;32:270–80.
Suppes T, Phillips KA, Judd CR. Clozapine treatment of non-psychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry. 1994;36:338–40.
Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry. 1999;56:1164–9.
Takahashi R, Sakuma A, Itoh H, Kurihara M, Saito M, Watanabe M. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Arch Gen Psychiatry. 1975;32:1310–18.
Tohen M, Zarate CA Jr. Antipsychotic agents and bipolar disorder. J Clin Psychiatry. 1998;59:38–48.
Tohen M, Zarate CA Jr, Centorrino F et al. Risperidone in the treatment of mania. J Clin Psychiatry. 1996;57:6:249–53.
Tohen M, Zhang F, Taylor C et al. A meta-analysis of the use of typical antipsychotics in bipolar disorders. J Affect Disord. 2000;69:l-9.
Tohen M, Sanger TM, McElroy SL et al. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry. 1999a;156:5:702–9.
Tohen M, Jacobs T, Grundy S et al. Efficacy of olanzapine in acute bipolar mania. A double-blind placebo controlled study. Arch Gen Psychiatry. 2000;57:841–9.
Tran PV, Hamilton SH, Kuntz AJ et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol. 1997;17:407–18.
Van Praag HM, Korf J, Dols LCW. Clozapine versus perphenazine. Br J Psychiatry. 1976;129:547–55.
Wood MJ, Rubinstein M. An atypical responder to clozapine (letter). Am J Psychiatry. 1990;147:369.
Zarate CA Jr, Tohen M, Baldessarini MD. Clozapine in severe mood disorders. J Clin Psychiatry. 1995a;56:9:411–16.
Zarate CA Jr, Tohen M, Banov MD et al. Is clozapine monotherapy a mood stabilizer? J Clin Psychiatry. 1995b;56:109–13.
Zarate CA Jr, Narendran R, Tohen M et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry. 1997;59:24–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Kluwer Academic Publishers
About this chapter
Cite this chapter
Tohen, M. (2000). Antipsychotics in acute mania. In: Marneros, A., Angst, J. (eds) Bipolar Disorders. Springer, Dordrecht. https://doi.org/10.1007/0-306-47521-9_18
Download citation
DOI: https://doi.org/10.1007/0-306-47521-9_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6588-4
Online ISBN: 978-0-306-47521-4
eBook Packages: Springer Book Archive